Published in Trop Med Int Health on April 01, 2006
Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ (2008) 4.46
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ (2008) 4.02
Costs and cost-effectiveness of malaria control interventions--a systematic review. Malar J (2011) 2.53
Dispensary level pilot implementation of rapid diagnostic tests: an evaluation of RDT acceptance and usage by providers and patients--Tanzania, 2005. Malar J (2008) 2.52
Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test. Malar J (2009) 2.38
Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands. Malar J (2008) 2.37
Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria-attributable fever during low and high transmission season in Burkina Faso. Malar J (2010) 1.88
Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J (2008) 1.77
Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J (2008) 1.76
Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries. Cochrane Database Syst Rev (2014) 1.71
Use and limitations of malaria rapid diagnostic testing by community health workers in war-torn Democratic Republic of Congo. Malar J (2009) 1.62
Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia. Cost Eff Resour Alloc (2009) 1.60
Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT. Malar J (2009) 1.59
Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One (2010) 1.46
Improving rational treatment of malaria: perceptions and influence of RDTs on prescribing behaviour of health workers in southeast Nigeria. PLoS One (2011) 1.41
Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malar J (2010) 1.35
Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31
Rapid diagnostic tests versus clinical diagnosis for managing people with fever in malaria endemic settings. Cochrane Database Syst Rev (2014) 1.31
Cost effectiveness of OptiMal® rapid diagnostic test for malaria in remote areas of the Amazon Region, Brazil. Malar J (2010) 1.25
Cost-effectiveness analysis of introducing RDTs for malaria diagnosis as compared to microscopy and presumptive diagnosis in central and peripheral public health facilities in Ghana. Am J Trop Med Hyg (2013) 1.19
Response to malaria epidemics in Africa. Emerg Infect Dis (2007) 1.16
Costs of treating malaria according to test results. BMJ (2008) 1.04
Willingness to pay for rapid diagnostic tests for the diagnosis and treatment of malaria in southeast Nigeria: ex post and ex ante. Int J Equity Health (2010) 1.01
Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso. Malar J (2011) 1.00
Cost-effectiveness of three malaria treatment strategies in rural Tigray, Ethiopia where both Plasmodium falciparum and Plasmodium vivax co-dominate. Cost Eff Resour Alloc (2011) 0.98
Cost-effectiveness of diagnostic for malaria in Extra-Amazon Region, Brazil. Malar J (2012) 0.96
Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan. Malar J (2015) 0.96
Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries. Health Econ (2016) 0.87
Qualitative study of presumptive treatment of childhood malaria in third tier tertiary hospitals in southeast Nigeria: a focus group and in-depth study. Malar J (2013) 0.85
Accuracy of an Immunochromatographic Diagnostic Test (ICT Malaria Combo Cassette Test) Compared to Microscopy among under Five-Year-Old Children when Diagnosing Malaria in Equatorial Guinea. Malar Res Treat (2010) 0.83
Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso. PLoS One (2013) 0.82
Diagnosis of Malaria Infection with or without Disease. Mediterr J Hematol Infect Dis (2012) 0.82
Factors associated with appropriate home management of uncomplicated malaria in children in Kassena-Nankana district of Ghana and implications for community case management of childhood illness: a cross-sectional study. BMC Public Health (2015) 0.75
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15
Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet (2010) 3.82
Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med (2005) 3.68
A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol (2003) 3.67
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
The dynamics of measles in sub-Saharan Africa. Nature (2008) 3.35
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg (2004) 3.18
Violence and mortality in West Darfur, Sudan (2003-04): epidemiological evidence from four surveys. Lancet (2004) 3.14
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
Fumagillin treatment of intestinal microsporidiosis. N Engl J Med (2002) 2.52
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis (2010) 2.24
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. JAMA (2010) 2.12
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis (2005) 2.06
Selection strength and hitchhiking around two anti-malarial resistance genes. Proc Biol Sci (2005) 2.04
Evaluation of a 5-year programme to prevent mother-to-child transmission of HIV infection in Northern Uganda. J Trop Pediatr (2009) 2.02
Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004. Emerg Infect Dis (2006) 2.01
Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria. Trans R Soc Trop Med Hyg (2007) 2.00
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg (2006) 1.92
The primacy of public health considerations in defining poor quality medicines. PLoS Med (2011) 1.91
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS (2007) 1.88
Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database. Malar J (2014) 1.86
Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J (2009) 1.86
Pre-emptive war epidemiology: lessons from the Democratic Republic of Congo. Lancet (2006) 1.83
Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage. J Clin Microbiol (2005) 1.82
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Malar J (2006) 1.80
A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis (2006) 1.80
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J (2009) 1.80
High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis (2006) 1.77
Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS (2007) 1.77
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J (2011) 1.76
Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis (2007) 1.75
The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72
Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda. PLoS Clin Trials (2006) 1.72
Don't spin the pen: two alternative methods for second-stage sampling in urban cluster surveys. Emerg Themes Epidemiol (2007) 1.71
Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health (2004) 1.61
Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS (2009) 1.60
Evaluation of three rapid tests for diagnosis of P. falciparum and P. vivax malaria in Colombia. Am J Trop Med Hyg (2006) 1.60
Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies. PLoS One (2012) 1.56
Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites. Mol Biol Evol (2005) 1.56
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J (2007) 1.56
Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra Leone. Emerg Infect Dis (2015) 1.56
Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Vaccine (2006) 1.53
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
Death rates from malaria epidemics, Burundi and Ethiopia. Emerg Infect Dis (2007) 1.51
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51
Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. BMC Infect Dis (2009) 1.50
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop Med Int Health (2005) 1.48
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe. Tuberculosis (Edinb) (2009) 1.43
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull World Health Organ (2006) 1.43
Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health (2011) 1.43
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg (2005) 1.40
Malaria in camps for internally-displaced persons in Uganda: evaluation of an insecticide-treated bednet distribution programme. Trans R Soc Trop Med Hyg (2004) 1.40
Bleach sedimentation: an opportunity to optimize smear microscopy for tuberculosis diagnosis in settings of high prevalence of HIV. Clin Infect Dis (2008) 1.38
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malar J (2006) 1.37
Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine (2010) 1.37
Mortality among displaced former UNITA members and their families in Angola: a retrospective cluster survey. BMJ (2003) 1.36
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrob Agents Chemother (2006) 1.36
The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J (2008) 1.29
Users' guides to the medical literature: how to use an article about mortality in a humanitarian emergency. Confl Health (2008) 1.28
Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ (2006) 1.25
Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan. Trop Med Int Health (2003) 1.23
The uncertain burden of Plasmodium falciparum epidemics in Africa. Trends Parasitol (2007) 1.22
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg (2005) 1.22
Public health surveillance after the 2010 haiti earthquake: the experience of médecins sans frontières. PLoS Curr (2013) 1.21
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience. PLoS Med (2008) 1.20
Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human african trypanosomiasis. PLoS Comput Biol (2013) 1.19
Public health. Getting HIV treatment to the most people. Science (2012) 1.19
Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Trop Med Int Health (2008) 1.18
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. Trop Med Int Health (2006) 1.18
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother (2013) 1.15
Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One (2010) 1.15
Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia. Trop Med Int Health (2005) 1.14
Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method. PLoS One (2009) 1.14